IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai (original) (raw)
- Regular Article
- Open access
- Published: 27 November 2001
British Journal of Cancer volume 85, pages 1695–1699 (2001) Cite this article
- 2352 Accesses
- 109 Citations
- 5 Altmetric
- Metrics details
This article has been updated
Abstract
This is the first study to investigate the associations of IGF-1, IGF-2 and IGFBP-3 concentrations with the risk of colorectal cancer in prospectively collected blood samples from an Oriental population. Between 1986 and 1989 serum samples were collected at baseline from 18 244 men, aged 45–65 years, without a history of cancer and living in Shanghai, China. IGF-1, IGF-2 and IGFBP-3 were measured in the serum of 135 men who developed colorectal cancer over 12 years of follow-up and 661 control subjects drawn from the cohort, who were matched to the index cases by neighbourhood of residence, age, and year and month of sample collection. Serum IGF-1 was not associated with risk of colorectal cancer. IGF-2 and IGFBP-3, on the other hand, exhibited statistically significant, positive associations with colorectal cancer risk when cases were confined to those diagnosed within a relatively short time period after enrolment (within 8 years). After adjustment for body mass index, cigarette smoking and alcohol intake, men in the highest versus the lowest quintile of IGF-2 and IGFBP-3 showed odds ratios of 2.74 (95% Cl = 1.67–4.50; 2-sided P for trend = 0.0008) and 2.85 (95% Cl = 1.69–4.81; 2-sided P for trend = 0.01), respectively. Our data thus suggest that circulating IGF-2 and IGFBP-3 can serve as early indicators of impending colorectal cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
- Cadoret A, Baron-Delage S, Bertrand F, Kornprost M, Groyer A, Gespach C, Capeau J and Cherqui G (1998) Oncogene-induced up- regulation of Caco-2-cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway. Oncogene 17: 877–887
Article CAS Google Scholar - Cui H, Horon I, Ohlsson R, Hamilton SR and Feinberg AP (1998) Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nature Med 4: 1276–1280
Article CAS Google Scholar - Di Popolo AD, Memoli A, Apicella A, Tuccillo C, Palma A, Ricchi P, Acquaviva AM and Zarrilli R (2000) IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells. Oncogene 19: 5517–5524
Article CAS Google Scholar - EI-Atiq F, Garrouste F, Remacle-Bonnet M, Sastre B and Pommier G (1994) Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int J Cancer 57: 491–497
Article Google Scholar - Ferry RJ, Cerri RW and Cohen P (1999) Insulin-like growth factor binding proteins: new proteins. new functions. Horm Res 51: 53–67
CAS PubMed Google Scholar - Freier S, Weiss O, Eran M, Flyvbjerg A, Dahan R, Nephesh I, Safra T, Shiloni E and Raz I (1999) Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 44: 704–708
Article CAS Google Scholar - Giovannucci E (1999) Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Horm Res 51, (Suppl 3) 34–41
CAS PubMed Google Scholar - Giovannucci E, Pollak MN, Platz EA, Willett WC and Stampfer MJ et al (2000) A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomark Prev 9: 345–349
CAS Google Scholar - Hassan AB and Howell JA (2000) Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res 60: 1070–1076
CAS PubMed Google Scholar - Hosmer DW and Lemeshow S (1989) Applied Logistic Regression. John Wiley & Sons: New York
- Jones JI and Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16: 3–34
CAS PubMed Google Scholar - Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE and Riboli E (2000) Serum C-peptide insulin-like growth factor-I (IGF-I). IGF-binding proteins and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592–1600
Article CAS Google Scholar - Kansra S, Ewton DZ, Wang J and Friedman E (2000) IGFBP-3 mediates TGF beta 1 response in colon cancer cells. Int J Cancer 87: 373–378
Article CAS Google Scholar - Lamonerie T, Lavialle C, Haddada H and Brison O (1995a) IGF- 2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line. Int J Cancer 61: 587–592
Article CAS Google Scholar - Lamonerie T, Lavialle C, de Galle B, Binoux M and Brison O (1995b) Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp Cell Res 216: 342–351
Article CAS Google Scholar - Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH and Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Nati Cancer Inst 91: 620–625
Article CAS Google Scholar - Manousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, Adami H-O and Mantzoros C (1999) IGF-I and IGF-II in relation to colorectal cancer. Int J Cancer 83: 15–17
Article CAS Google Scholar - Renehan AG, Painter JE, O’Halloran D, Atkin WS, Potten CS, O’Dwyer ST and Shalet SM (2000) Circulating insulin-like growth factor II and colorectal adenomas. J Clin Endocrinol Metab 85: 3402–3408
CAS PubMed Google Scholar - Szepeshazi K, Schally AV, Groot K, Armatis P, Halmos G, Herbert F, Szende B, Varga JL and Zarandi M (2000) Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers. Br J Cancer 82: 1724–1731
Article CAS Google Scholar - Thissen JP, Ketelslegers JM and Underwood LE (1994) Nutritional regulation of the insulin-like growth factors. Endocrine Reviews 15: 80–101
CAS PubMed Google Scholar - Yuan JM, Ross RK, Wang XL, Gao Y-T, Henderson BE and Yu MC (1996) Morbidity and mortality in relation to cigarette smoking in Shanghai. China. JAMA 275: 1646–1650
Article CAS Google Scholar - Zou T, Fleisher A, Kong D, Yin J, Souza R, Wang S and Smolinski KN (1998) Abraham JM, Meltzer SJ. Sequence alterations of IGFBP3 in neoplastic and normal gastrointestinal tissues. Cancer Res 58: 4802–4804
CAS PubMed Google Scholar
Author information
Authors and Affiliations
- Institute of Social and Preventive Medicine, University of Basel, Steinengraben, 49, 4051, Basel, Switzerland
N M Probst-Hensch - USC/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, 90033, CA, USA
R K Ross & M C Yu - Dept. of OB/GYN, Keck School of Medicine, University of Southern California, Los Angeles, 90033, CA, USA
J-M Yuan & F Z Stanczyk - Shanghai Cancer Institute, Shanghai, 200032, People’s Republic of China
Y-T Gao
Authors
- N M Probst-Hensch
- J-M Yuan
- F Z Stanczyk
- Y-T Gao
- R K Ross
- M C Yu
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Probst-Hensch, N., Yuan, JM., Stanczyk, F. et al. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai.Br J Cancer 85, 1695–1699 (2001). https://doi.org/10.1054/bjoc.2001.2172
- Received: 12 June 2001
- Revised: 05 September 2001
- Accepted: 10 September 2001
- Published: 27 November 2001
- Issue date: 01 December 2001
- DOI: https://doi.org/10.1054/bjoc.2001.2172